Azioni Acerus Pharmaceuticals Corporation Toronto S.E.
Azioni
ASP
CA00444G4051
Prodotti farmaceutici
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Variaz. 1 gen. | Capi. | |
---|---|---|
+38,15% | 705 Mrd | |
+32,82% | 583 Mrd | |
-3,71% | 364 Mrd | |
+20,01% | 332 Mrd | |
+4,93% | 291 Mrd | |
+16,64% | 238 Mrd | |
-4,13% | 210 Mrd | |
+10,63% | 209 Mrd | |
+8,49% | 169 Mrd |